MA Health Insurers Have Made Good Progress in Price Transparency, But Significant Work Remains

Share on Facebook
Share on Twitter
Share on
LinkedIn
+

Read press coverage of this report in the Boston Business Journal and State House News Service.

Tools are more user friendly and cover growing number of procedures, but still used by just a small fraction of potential market

BOSTON – A Pioneer Institute study finds some significant improvements in the online cost estimator tools created by Massachusetts’ three largest health insurers, but there is much still to be done for the carriers to maximize the opportunity price transparency represents.

Online cost estimator tools give consumers/plan members online information about a range of information for outpatient and many inpatient procedures. These tools display the amount that has to be paid by consumers to any particular provider, how much the plan pays the provider, and information about provider quality.  Consumers can compare several providers at the same time.

“Price transparency can help initiate reforms that reduce healthcare costs and allow market forces to drive patients to lower-cost, higher-value providers,” said Barbara Anthony, primary author of MA Health Insurers Have Improved Their Consumer Price Transparency Efforts, But Significant Work Remains.

A 2012 state law required health insurers to develop online cost estimator tools by October 2014.  In 2015, the advocacy group Health Care for All (HCFA) assessed the tools developed by Blue Cross Blue Shield (BCBS), Harvard Pilgrim Health Care (HPHC), and Tufts Health Plan, which together controlled nearly four-fifths of the state health insurance market.  HCFA gave each a grade of “C.”

The same law also requires hospitals and doctors to provide consumers with prices of services upon request. Previous Pioneer studies showed very poor compliance by Massachusetts providers with the Commonwealth’s transparency law.

As a follow up to the HCFA study, in late 2017, Pioneer assessed the same carriers’ performance and found their tools more user friendly.  They cover between 700 and 1600 procedures, a vast improvement over the initial numbers of procedures available in 2015.  Importantly, Pioneer found that all three carriers are embracing incentive/reward programs to attract workers at entities with 250 or more employees to lower-cost, high-value providers.  Pioneer’s study was done with the full cooperation of the carriers.

Under incentive/rewards programs, employees are rewarded by either small or no co-payments or cash rewards from $25 to several hundreds of dollars for choosing lower-cost, high-value providers such as outpatient surgical centers rather than a hospital outpatient clinic. HPHC has developed a program called SaveOn that makes it easier for members to switch providers to avoid co-pays or earn cash rewards.  BCBS has aggressively embraced and marketed cash incentive programs to both businesses and municipalities.  In all cases, the plans say they are embracing incentive programs and transparency to compete with large national carriers here and regionally.

Both the HPHC’s and THP’s tools are a significant improvement over their initial cost estimator tools.   After their common vendor pulled out of the market, the carriers had to entirely revamp their tools. The results are new, easy-to-navigate online tools which display out-of-pocket consumer costs, the remaining deductible, and quality metrics.

Since 2015, BCBS has made several improvements that make its product more consumer friendly: by simply changing the name of its tool from “Find a Doc” to “Find a Doc and Estimate Costs,” by making the tool much more prominent on its website, and clearly showing both out-of-pocket costs and remaining deductibles. BCBS also has an improved website for consumers.

Despite significant progress, however, deficiencies remain. The carriers had about 297,000 aggregate inquiries on their cost estimator tools from early 2014 through 2017, compared to a potential market of at least three million people that the three carriers cover.

“The number of aggregate inquiries shows that carriers still have a lot of work ahead to achieve price transparency’s potential to rein in healthcare costs,” said Pioneer Institute Executive Director Jim Stergios.

In 2015, Massachusetts’ median annual household income was around $70,000 and the average family in the Commonwealth spent about $20,000 on premiums and cost sharing.  “These figures show that transparency in healthcare is important to the budgets of Massachusetts families,” added Stergios.

HPHC’s and Tufts’ estimator tools still don’t provide cost data on many behavioral health procedures.

The BCBS site is compatible with online translation tools, but none of the carriers’ cost estimator tools are readily available in a language other than English.

Anthony noted that “While state government has not provided any compliance leadership for consumer price transparency, now, after overcoming resistance and a lack of support, the market is waking up to the potential benefits of price transparency and incentive programs.”

Comments from Harvard Pilgrim Health Care, Blue Cross Blue Shield and Tufts Health Plan:

“In a rapidly changing healthcare environment, providing consumers with transparency around cost and quality information is important and will help them make informed healthcare choices,” said Harvard Pilgrim President and CEO Eric Schultz. “We at Harvard Pilgrim have long been committed to promoting the value of transparency, and we are pleased to see that Pioneer Institute continues to keep a public focus on the issue. We were happy to work with them on this report.”

“Blue Cross is pleased that the Pioneer report acknowledges our ongoing commitment to providing our members with state-of-the-art tools to make informed decisions about the cost and quality of their healthcare.  Members who understand their benefits – those who aren’t surprised by bills and feel empowered – are much more likely to be satisfied members and engaged patients. I thank Pioneer Institute for their continued focus on this issue,” said Andrew Dreyfus, BCBS President and CEO.

“Transparency is essential among all stakeholders in healthcare to ensure that customers and employer groups can make informed healthcare decisions,” said Tom Croswell, President and CEO at Tufts Health Plan. “[O]ur new, easy-to-use tool enables members to not only find high-quality, high-value providers in their area, but also see their potential costs from the beginning to the end of a procedure. The new tool is simpler and far surpasses the capabilities of the first generation of transparency tools. We applaud Pioneer Institute’s work on keeping this important issue at the forefront.”

About the Authors

Barbara Anthony, a lawyer, is a senior fellow in healthcare at Pioneer Institute focusing on healthcare price and quality transparency.  She is also an associate at the Harvard Kennedy School’s Center for Business and Government.  She served as Massachusetts Undersecretary for Consumer Affairs and Business Regulation from 2009 to 2015.

Scott Haller graduated from Northeastern University with a Bachelor’s Degree in Political Science. He started working at Pioneer Institute through the Northeastern’s Co-op Program and continues now as the Lovett C. Peters Fellow in Healthcare. He previously worked at the Office of the Inspector General.

About Pioneer

Pioneer Institute is an independent, non-partisan, privately funded research organization that seeks to improve the quality of life in Massachusetts through civic discourse and intellectually rigorous, data-driven public policy solutions based on free market principles, individual liberty and responsibility, and the ideal of effective, limited and accountable government.

Get Updates On Our Healthcare Research and Events!

Related Posts

Massachusetts Telehealth Report Card: Are We Embracing Disruption for Better Quality of Care?

Hubwonk host Joe Selvaggi talks with Pioneer Senior Fellow in Healthcare Josh Archambault about his newest research paper, produced with the Cicero Institute and the Reason Foundation, on states' success in implementing telehealth to improve healthcare outcomes. They discuss how Massachusetts has used remote medicine to better reach patients and serve their needs.

Am I Contagious? Divining Covid’s Community Conundrum

Hubwonk host Joe Selvaggi talks with Alva10 CEO and precision medicine expert Hannah Mamuszka about which tests are best for determining who is contagious and the implications for the CDC’s new isolation recommendations.

Study rates every state’s telehealth laws for patient access and ease of providing services

A new report from Reason Foundation, Cicero Institute and Pioneer Institute rates every state’s telehealth policy for patient access and ease of providing virtual care. The report highlights telehealth policy best practices for states.

Face Masks Lifted: Scientists Weigh In With Comprehensive Efficacy Studies

Hubwonk host Joe Selvaggi talks with Harvard Medical School professor, Dr. Jonathan Darrow, about the observations of his recent paper, Evidence for Community Cloth Face Masking to Limit the Spread of SARS-CoV-2: A Critical Review, in which he examines the range, quality, and scientific observations of mask wearing efficacy studies.

Building Healthcare Bigger: New Bill Is Good Medicine or Ill-Designed Cost Shift

This week on Hubwonk, host Joe Selvaggi talks with Josh Archambault, Pioneer Institute’s Senior Fellow in Healthcare, about the healthcare provisions in the pending Build Back Better Act and their likely impact on the coverage and cost to Americans in the wake of Covid-19.

The Promise and Challenges of Rare Cancer Treatments

Dr. William Smith, Pioneer Institute's Visiting Fellow in Life Sciences, spoke about the challenges and opportunities for rare cancer treatments, in a video interview produced by Rare Cancers, a patient group based in Australia, for the November 26th CAN Forum. 

COVID’s Unintended Victims: Traditional Diseases Overlooked at the Public’s Peril

This week on Hubwonk, host Joe Selvaggi talks with Pioneer Institute’s Visiting Fellow in Life Sciences, Dr. Bill Smith, about his newest research paper, “An “Impending Tsunami” in Mortality from Traditional Diseases,” which sounds the alarm that the public health community’s focus on COVID-19 has caused many to avoid seeking medical attention for other illnesses. As a result, more Americans are dying from fear of COVID than from the disease itself.

Vaccine Development Renaissance: Pandemic Brings Niche Industry into Mainstream

This week on Hubwonk, host Joe Selvaggi talks with virologist, Dr. Peter Kolchinsky, about the explosion of vaccine technologies and innovations brought into the spotlight by the massive investment to fight the pandemic, and dives deeply into the exciting promise of vaccines to combat an ever-widening range of disease.

Shifting COVID-19 Goalposts: Moving from Zero Infections to Zero Deaths

This week on Hubwonk, host Joe Selvaggi talks with surgeon and author Dr. Marty Makary about the power and durability of vaccines, natural immunity and clinical therapies, that are overshadowed by the public health community's continued target of zero COVID-19 infections.

An Act advancing health care research and decision-making centered on patients and people with disabilities

On November 9th, 2021, William Smith, Pioneer Institute Visiting Fellow in Life Sciences, submitted the following testimony to the Massachusetts Legislature in support of House Bill 201, which addresses a number of flaws and infirmities in the Quality Adjusted Life Years (QALYs) methodology that is utilized by a number of foreign nations in evaluating the value of medicines.

Study: Decline in Cardiovascular Health Screenings During COVID-19 Pandemic Poses New Public Health Threat

Pioneer Institute today released a new analysis focused on cardiovascular disease, An “Impending Tsunami” in Mortality from Traditional Diseases?, that examines how the COVID-19 pandemic has created another unrelated public health crisis. The Pioneer analysis examines how a single-minded public health focus on COVID-19, social distancing, and lockdowns drove reductions in screenings, diagnoses, and early treatment for complex conditions such as heart disease.

A Modest Proposal to Raise Federal Revenue

As a way to tackle drug prices, President Joe Biden recently announced that he supports the so-called “inflation rebate,” which would require drug companies to give the federal government any revenue from Medicare drug prices above the general rate of inflation. Senate Finance Committee Chairman Ron Wyden and House Speaker Nancy Pelosi have also publicly endorsed the inflation rebate.

Why are health care costs rising every year in Massachusetts?

/
The largest driver is the increase in prices by health systems that have the clout to command higher payments and work to recruit more patients to their high-cost facilities.

Untangling Variants & Outbreaks: Can Vaccines & Natural Immunity Outrun Delta?

Hubwonk host Joe Selvaggi talks with author, surgeon, and public health expert Dr. Marty Makary about the COVID-19 Delta Variant, the durability of natural and vaccinated immunity, the benefits of booster shots, and the health risks for children as we move into the fall.

Targeting Pharma: Infrastructure Bill Employs Price Controls To Offset Unprecedented Price Tag

Hubwonk host Joe Selvaggi talks with Pioneer Institute Visiting Fellow in Life Sciences Dr. William Smith about how the price control features of the emerging $3.5 trillion infrastructure bill might affect the pharmaceutical Industry, both nationwide and here in Massachusetts, and what effect that change will have on drug consumers.

Pioneer Institute Statement on the Commonwealth’s Discontinuance of the COVID-19 Weekly Public Health Report

Useful information about COVID cases or deaths at individual homes has become less available at a time when cases are increasing again, even among vaccinated residents. Pioneer urges Massachusetts to immediately reinstate the so-called Weekly Report, which contains cases and deaths inside individual nursing homes.

Alzheimer Breakthrough Disillusionment: Confusion on FDA’s Approval of Expensive and Possibly Ineffective Drug

Hubwonk host Joe Selvaggi talks with precision medicine expert Hannah Mamuszka and Pioneer Institute's Bill Smith about the promises and pitfalls of the newly approved Alzheimer’s drug Aduhelm, and the challenges presented when new, expensive drugs of dubious benefit are introduced to the nation’s formulary.

Comparing Covid-19 Vaccination and New Infection Rates in Suffolk County: Is Vaccination Working?

/
Massachusetts ranks fourth nationally for the highest percent…